Apr 08, 2020
Biotechs Fast Track Repurposing Existing Drugs for COVID-19 Treatments
Apr 01, 2020
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
Mar 20, 2020
University Hospitals among first in nation to test investigational antiviral drug against COVID-19
Mar 19, 2020
Coronavirus (COVID-19) Update: FDA Continues to Facilitate Development of Treatments
Mar 09, 2020
Actinic Keratosis Treatment Market to Reach $1.56 Bn, Globally, by 2026 at 4.2% CAGR: Allied Market Research
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Mar 02, 2020
Primmune Therapeutics Raises $7 Million Seed Financing to Develop Novel Oral TLR7 Immunotherapies for Cancer and Acute Viral Diseases
Feb 27, 2020
$200B+ Cancer Immunotherapy Market Opportunity Insights, 2026 - Cancer Vaccines, Monoclonal Antibodies, Trials of T-Cell Therapies, Pipeline Overview, Competitive Landscape, and More
Dec 09, 2019
CARsgen Therapeutics Receives IND Clearance from the NMPA for AB011 Humanized Claudin18.2 Monoclonal Antibody
Nov 11, 2019
NKMax America Announces Executive Advisory Board
Nov 11, 2019
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
Aug 20, 2019
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
Aug 12, 2019
PALM Ebola Clinical Trial Stopped Early as Regeneron's REGN-EB3 Therapy Shows Superiority to ZMapp in Preventing Ebola Deaths
Jul 17, 2019
Oblique Therapeutics has been Recognized as one of the 15 Most Promising Biotech Startups in Europe 2019, by StartUp City Magazine
Mar 26, 2019
Eiger BioPharmaceuticals to Participate in Conferences in April
Mar 06, 2019
Inosine (CAS 58-63-9): Global Market Research Report, 2019 - ResearchAndMarkets.com
Feb 21, 2019
PharmaEssentia and AOP Orphan Receive EU Approval of Besremi(TM) (Ropeginterferon Alfa-2b) for Treatment of Polycythemia Vera (PV) in EU
Feb 18, 2019
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics
Jan 25, 2019
Global HIV Competitor Landscape Report 2018: Timeline Forecasts for Each Approved Product's Lifecycle Management Initiatives
Dec 05, 2018
PharmaEssentia Updates Progress of Ropeginterferon Alfa-2b Clinical Program